MJ MedTech and Illumina Deepen Collaboration: DRAGEN Platform Empowers Precision Medicine
Illumina
Diagnostic Product Developer
Recently,Maijie Translational Medicine Research (Suzhou) Co., Ltd. (referred to as "Maijie Medicine")Global Sequencing LeaderIllumina Deepens Cooperation, the advanced Illumina DRAGEN platform has been introduced once again. This move marks a significant step for MedGenome in next-generation sequencing (NGS).There has been a new leap in the field of data processing, especially inOncology、GeneticsIn the field of precision medicine, it will further enhance the speed and accuracy of data analysis, facilitating scientific research innovation and breakthroughs.
Powerful Combination, Advantages Stand Out
Illumina DRAGEN Platform Will Collaborate withTSO500 panel Seamless integration provides strong support for comprehensive cancer genomic testing.TSO500 Coverage523 Tumor-Related GenesAndImmune Group, capable of precise detectionTargeted Variation、Microsatellite Instability (MSI)、Tumor Mutation Burden (TMB)And other key indicators.
DRAGEN'sUltraRapid Data AnalysisCapabilities will significantly shorten the delivery cycle while maintainingHigh Precision, Empowering OncologyMolecular Subtyping、Early ScreeningAndPersonalized Treatment PlanOptimization。
Maijie Medicine: Comprehensive Layout of Precision Medicine
Since its establishment in 2013, Majie Medicine has been committed to creatingIntegrated Translational Medicine Platform, providing comprehensive support for drug clinical translation, companion diagnostics (CDx) development, and medication guidance. Relying on strong technical capabilities, the company has equipped itself withNovaSeq™ 6000、HiSeq™ X Ten、NextSeq™ 500And10x GenomicsIncluding multiple advanced sequencing devices, forming fromMRD Detection, WGS Whole Genome Sequencing, WES Whole Exome SequencingToSingle-cell Genomics/Transcriptomics SequencingAnd other comprehensive testing capabilities.
Data Empowerment, Driving Scientific Research Breakthroughs
Maijie Medical's Data Bioinformatics Center focuses on providingPersonalized Bioinformatics Analysis Services, covering fromProgram Design, Data AnalysisToResult InterpretationThe entire process. This time, the introduction ofDRAGEN PlatformWill further enhance data processing capabilities, especially when dealing with large-scale tumor data and complex genetic information, ensuring a dual improvement in delivery speed and accuracy, forClinical ResearchAndBasic ResearchProvide strong support.
In the future, Majie Medicine will continue to promotePrecision MedicineAndTurnChemical MedicineThe deep integration, hand in hand with industry partners, jointly opens a new chapter in the field of life sciences!